Early localised prostate cancer may accelerate after 15 years

Technologies for early localised prostate cancer

Quality of life three years after diagnosis of localised prostate cancer: population based cohort study

OBJECTIVE To quantify the risk and severity of negative effects of treatment for localised prostate cancer on long term quality of life. DESIGN Population based, prospective cohort study with follow-up over three years. SETTING New South Wales, Australia. PARTICIPANTS Men with localised prostate cancer were eligible if aged less than 70 years, diagnosed between October 2000 and October 20...

Diagnosis, management and screening of early localised prostate cancer.

The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, particularly the increasingly elderly population and, more importantly, the increasing number of cases identified following prostate specific antigen (PSA) testing. It is commonly quoted that many more men die with prostate cancer than of it. Autopsy/post-mortem studies show that while a very high propor...

[Photodynamic therapy in localised prostate cancer].

Photodynamic therapy is based on the administration of an energy source in form of light of a specific wavelength, on a previously photosensitized tissue by a chemical compound, in the presence of oxygen, so that the great deal of free radicals and oxygen derivatives generated (hydroxyl compounds) produces necrosis of the treated tissue. Technique improvement during the last years has allowed i...

Surgery versus radiotherapy for localised prostate cancer

TRIAL EVIDENCE LACKING Despite millions of men having undergone these prostate cancer treatments, no randomised controlled trial evidence currently exists to compare their effectiveness. The only such trial underway, the ProtecT study, will not report until 2016 and may have limited generalisability due to differences in the randomised population and the prostate cancer population at large.3 Al...